Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-10 Sale |
2025-03-12 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,242 | $499.99 | $1,620,968 | 51,239 (Direct) |
View |
2025-03-04 Sale |
2025-03-06 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,058 | $485.49 | $1,970,118 | 54,481 (Direct) |
View |
2025-02-27 Sale |
2025-02-28 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
530 | $475.34 | $251,930 | 58,539 (Direct) |
View |
2025-02-25 Sale |
2025-02-26 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
354 | $480.95 | $170,256 | 64,031 (Direct) |
View |
2025-02-18 Sale |
2025-02-19 4:36 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
244 | $455.06 | $111,035 | 67,695 (Direct) |
View |
2025-02-11 Sale |
2025-02-12 4:50 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
310 | $459.83 | $142,547 | 64,021 (Direct) |
View |
2024-06-03 Sale |
2024-06-05 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,175 | $460 | $1,000,500 | 49,098 (Direct) |
View |
2024-05-30 Sale |
2024-06-03 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,600 | $441.99 | $2,033,159 | 51,273 (Direct) |
View |
2024-02-26 Sale |
2024-02-27 5:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
354 | $425.7 | $150,698 | 55,804 (Direct) |
View |
2024-02-21 Sale |
2024-02-23 4:28 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
360 | $421.77 | $151,837 | 59,467 (Direct) |
View |
2024-02-20 Sale |
2024-02-21 4:43 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
480 | $420.79 | $201,979 | 59,827 (Direct) |
View |
2024-02-12 Sale |
2024-02-13 5:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
314 | $420.24 | $131,955 | 68,179 (Direct) |
View |
2023-08-23 Sale |
2023-08-25 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,500 | $355 | $887,500 | 48,637 (Direct) |
View |
2023-08-10 Sale |
2023-08-14 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
5,750 | $345.79 | $1,988,293 | 51,137 (Direct) |
View |
2023-02-27 Sale |
2023-02-28 5:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
354 | $287.48 | $101,768 | 56,805 (Direct) |
View |
2023-02-21 Sale |
2023-02-22 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
480 | $293.75 | $141,002 | 60,467 (Direct) |
View |
2023-02-14 Sale |
2023-02-16 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
320 | $298.52 | $95,527 | 65,445 (Direct) |
View |
2023-02-13 Sale |
2023-02-14 5:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
275 | $298.99 | $82,223 | 65,765 (Direct) |
View |
2022-08-09 Sale |
2022-08-10 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,400 | $298.97 | $418,557 | 46,090 (Direct) |
View |
2022-03-17 Sale |
2022-03-21 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,833 | $250.11 | $708,572 | 47,356 (Direct) |
View |
2022-02-25 Sale |
2022-02-28 5:27 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
325 | $230.95 | $75,058 | 50,189 (Direct) |
View |
2022-02-18 Sale |
2022-02-22 5:03 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
519 | $231 | $119,889 | 53,104 (Direct) |
View |
2022-02-11 Sale |
2022-02-14 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
290 | $235.09 | $68,175 | 57,737 (Direct) |
View |
2020-05-15 Sale |
2020-05-19 4:33 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer |
120 | $284 | $34,080 | 12,738 (Direct) |
View |
2020-05-06 Sale |
2020-05-08 4:28 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer |
966 | $272.7 | $263,431 | 21,737 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-26 Tax Withholding |
2025-02-28 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,962 | $479.61 | 58,539 (Direct) |
View |
2025-02-24 Tax Withholding |
2025-02-26 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,310 | $483.28 | 64,031 (Direct) |
View |
2025-02-14 Tax Withholding |
2025-02-19 4:36 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,293 | $463.46 | 67,695 (Direct) |
View |
2025-02-12 Option Award |
2025-02-14 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
6,211 | $0 | 70,232 (Direct) |
View |
2025-02-10 Tax Withholding |
2025-02-12 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,143 | $467.98 | 64,021 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
17,376 | $0 | 66,474 (Direct) |
View |
2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | Tatsis Ourania Director |
267,541 | $0 | 267,541 (Direct) |
View |
2024-02-23 Tax Withholding |
2024-02-27 5:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,309 | $431.79 | 55,804 (Direct) |
View |
2024-02-16 Tax Withholding |
2024-02-21 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,499 | $424.01 | 59,827 (Direct) |
View |
2024-02-20 Tax Withholding |
2024-02-21 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,373 | $420.58 | 59,827 (Direct) |
View |
2024-02-09 Tax Withholding |
2024-02-13 5:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,100 | $422.74 | 68,179 (Direct) |
View |
2024-02-06 Option Award |
2024-02-08 4:45 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
21,956 | $0 | 70,593 (Direct) |
View |
2023-02-24 Tax Withholding |
2023-02-28 5:11 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,308 | $289.12 | 56,805 (Direct) |
View |
2023-02-17 Tax Withholding |
2023-02-22 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,498 | $292.85 | 60,467 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-14 5:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,995 | $298.26 | 65,765 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 5:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,377 | $294.33 | 65,765 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 5:01 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
24,322 | $0 | 70,412 (Direct) |
View |
2022-02-24 Tax Withholding |
2022-02-28 5:27 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,590 | $227.86 | 50,189 (Direct) |
View |
2022-02-17 Tax Withholding |
2022-02-22 5:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,114 | $232.51 | 53,104 (Direct) |
View |
2022-02-10 Tax Withholding |
2022-02-14 4:22 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,230 | $237.74 | 57,737 (Direct) |
View |
2022-02-01 Option Award |
2022-02-03 4:27 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
27,714 | $0 | 59,257 (Direct) |
View |
2021-02-24 Tax Withholding |
2021-02-26 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,036 | $217.57 | 31,432 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-19 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,000 | $211.75 | 32,468 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-12 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,230 | $214.16 | 34,468 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:59 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
22,960 | $0 | 35,698 (Direct) |
View |
2020-05-06 Exercise |
2020-05-08 4:28 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer |
966 | $0 | 21,737 (Direct) |
View |
2020-05-06 Exercise |
2020-05-08 4:28 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer |
559 | $187.53 | 21,737 (Direct) |
View |
2020-05-06 Exercise |
2020-05-08 4:28 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer |
407 | $155.57 | 21,737 (Direct) |
View |